Literature DB >> 7777278

Choroidal hypoperfusion in acute posterior multifocal placoid pigment epitheliopathy. An indocyanine green angiography study.

L J Howe1, H Woon, E M Graham, F Fitzke, A Bhandari, J Marshall.   

Abstract

BACKGROUND: The pathogenesis of acute posterior multifocal placoid pigment epitheliopathy remains obscure. The placoid lesions and characteristic findings on fluorescein angiography have been interpreted as representing either primary disease of the retinal pigment epithelium or disease of the choroidal vasculature. This study used indocyanine green (ICG) choroidal videoangiography to investigate this controversy.
METHODS: Sequential choroidal videoangiography was performed with ICG and a scanning laser ophthalmoscope on patients with acute posterior multifocal placoid pigment epitheliopathy. Image analysis was used to differentiate between masking and ischemia as to the cause of hypofluorescence on the angiograms.
RESULTS: Indocyanine green angiograms of acute posterior multifocal placoid pigment epitheliopathy showed areas of hypofluorescence in both the early and late pictures that correlated with the placoid lesions. Image analysis identified these as areas of choroidal hypoperfusion. Successive films showed partial or complete resolution of these hypofluorescent areas.
CONCLUSIONS: Indocyanine green choroidal videoangiography has shown choroidal hypoperfusion to underlie the pathogenesis of acute posterior multifocal placoid pigment epitheliopathy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7777278     DOI: 10.1016/s0161-6420(95)30955-4

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  24 in total

1.  Quantitative Analysis of Ellipsoid Zone in Acute Posterior Multifocal Placoid Pigment Epitheliopathy.

Authors:  Andrew W Browne; Waseem Ansari; Ming Hu; Kimberly Baynes; Careen Y Lowder; Justis P Ehlers; Sunil K Srivastava
Journal:  J Vitreoretin Dis       Date:  2020-02-11

Review 2.  [Choroiditis].

Authors:  S Thurau; G Wildner
Journal:  Ophthalmologe       Date:  2010-01       Impact factor: 1.059

3.  Increased choroidal blood flow velocity with regression of acute posterior multifocal placoid pigment epitheliopathy.

Authors:  Kiriko Hirooka; Wataru Saito; Michiyuki Saito; Yuki Hashimoto; Shohei Mori; Kousuke Noda; Susumu Ishida
Journal:  Jpn J Ophthalmol       Date:  2016-03-28       Impact factor: 2.447

4.  [White dot syndromes : Principles, diagnostics, and treatment].

Authors:  Dominika Pohlmann; Sibylle Winterhalter; Uwe Pleyer
Journal:  Ophthalmologe       Date:  2019-12       Impact factor: 1.059

5.  Cone photoreceptor abnormalities correlate with vision loss in a case of acute posterior multifocal placoid pigment epitheliopathy.

Authors:  In Hwan Hong; Sung Pyo Park; Ching Lung Chen; Hyoung Kyun Kim; Stephen H Tsang; Stanley Chang
Journal:  Ophthalmic Surg Lasers Imaging Retina       Date:  2014 Jan-Feb       Impact factor: 1.300

6.  Persistent placoid maculopathy: a new clinical entity.

Authors:  Pamela R Golchet; Lee M Jampol; David Wilson; Lawrence A Yannuzzi; Michael Ober; Edward Stroh
Journal:  Trans Am Ophthalmol Soc       Date:  2006

7.  Fluorescein and indocyanine green angiography for uveitis.

Authors:  Carl P Herbort
Journal:  Middle East Afr J Ophthalmol       Date:  2009-10

8.  Idiopathic choroidal neovascularisation as the inaugural sign of multiple evanescent white dot syndrome.

Authors:  Marina Papadia; Carl P Herbort
Journal:  Middle East Afr J Ophthalmol       Date:  2010-07

9.  Multifocal electroretinographic evaluation of macular function in acute posterior multifocal placoid pigment epitheliopathy.

Authors:  Ranko Aoyagi; Takaaki Hayashi; Tamaki Gekka; Kenichi Kozaki; Hiroshi Tsuneoka
Journal:  Doc Ophthalmol       Date:  2013-03-08       Impact factor: 2.379

10.  Videofunduscopy and videoangiography using the scanning laser ophthalmoscope in Vogt-Koyanagi-Harada syndrome.

Authors:  A A Okada; T Mizusawa; J Sakai; M Usui
Journal:  Br J Ophthalmol       Date:  1998-10       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.